Read it here:
http://www.nytimes.com/2015/10/16/business/lawsuit-accuses-sloan-kettering-of-delaying-gene-therapy-for-rare-blood-disease.html?_r=0
From his days as a troubled teenager on the gritty South Side of Chicago, Patrick Girondi has never shirked a fight.
Even on his way to making a fortune as a commodities trader, he said, he was fired from one job for “socking someone” on the trading floor.
Now Mr. Girondi, a high school dropout, is in a fight of a different kind — against the august Memorial Sloan Kettering Cancer Center over the rarefied field of gene therapy. It is a fight, he said, to save his son.
Mr. Girondi accuses the cancer center of dawdling on developing a gene therapy that could potentially cure his son of an inherited blood disease called beta thalassemia, or Cooley’s anemia. The disease often kills people by their late 20s — an age his son will reach in a few years.
No comments:
Post a Comment